Neurogene Inc
NASDAQ: NGNENew York, US · Founded 2018 · Delaware corporation · 139 employees on LinkedIn · 1 known investors
Accelerating development of new genetic medicines for people with devastating neurological diseases.
Founders & leadership
Neurogene Inc was founded in 2018 by Rachel McMinn.
RM
Rachel McMinnFounder
Board
CF
Cory FreedlandBoard director
SB
Stephen BiggarBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$106.5M disclosed across 2 rounds · 2019–2020
▶$69MraisedDec 2020 · 32 investors · OtherRule 506(b)
▶$69MraisedDec 2020 · 32 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Rachel McMinnExecutive Officer, Director
- Christine Mikail CvijicExecutive Officer
- Robert BaffiDirector
- Caroline StoutDirector
- Cory FreedlandDirector
- Srdjan StankovicDirector
- Stephen BiggarDirector
- Offering amount
- $115M
- Amount sold
- $69M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$37.5MraisedFeb 2019 · 13 investors · OtherRule 506(b)
▶$37.5MraisedFeb 2019 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Cory FreedlandDirector
- Rachel McMinnExecutive Officer, Director
- Stephen BiggarDirector
- Offering amount
- $37.5M
- Amount sold
- $37.5M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Neurogene Inc do?
- Accelerating development of new genetic medicines for people with devastating neurological diseases.
- Who founded Neurogene Inc?
- Neurogene Inc was founded by Rachel McMinn in 2018.
- Who are Neurogene Inc's investors?
- Neurogene Inc's investors include Samsara BioCapital.
- How much funding has Neurogene Inc raised?
- Neurogene Inc has disclosed $106.5M raised across 2 rounds.
- Where is Neurogene Inc headquartered?
- Neurogene Inc is headquartered in New York, US.